OClawVPS.com
OCULOGICA
Edit

OCULOGICA

http://www.oculogica.com/
Last activity: 06.11.2023
Probably Closed
Categories: AnalyticsDataDiagnosticsHealthTechHomeInformationPersonalProductSportsTechnology
The EyeBOX is as powerful as it is easy to use. In under 4 minutes, Oculogica’s proprietary technology collects and analyzes over 100,000 data points across 67-domains of eye movement to generate an objective assessment of concussion that is unique to each patient.

Detailed, real-time information on TBI and concussion facilitates rapid and precise diagnosis and improved patient outcomes. The EyeBOX requires no baseline data nor individual calibration, and therefore results cannot be influenced by patient will.

Baseline-free
Proprietary EyeBOX technology generates quick and accurate analysis without the need for pre-incident patient data.

Objective
67-point analysis enables greater diagnostic precision and improved patient outcomes. Unlike current standards of care, the EyeBOX goes beyond symptoms to measure brain function.

Easy to Use
Simple, calibration-free testing requires no literacy, language fluency or the ability to follow special directions. Accurate evaluation can be achieved in pre-verbal and verbally impaired patients.
Likes
39
Followers
485
Followers
1.27K
Mentions
19
Location: United States, New York
Employees: 11-50
Total raised: $8M
Founded date: 2013

Investors 7

Funding Rounds 1

DateSeriesAmountInvestors
21.01.2020-$8M-

Mentions in press and media 19

DateTitleDescription
06.11.2023OcuPro Roadside Cannabis Test featured on Kare 11OcuPro, a new device from Oculogica for testing impairment after cannabis use, was featured on Kare 11 News.
20.04.2023New Roadside Cannabis Test to Be Piloted by Police Departments Across the U.S.Neuro-diagnostic company Oculogica today announced the launch of OcuPro, the fastest roadside cannabis test with immediate results, along with pilots planned with several police departments across the U.S. Officers administer the 45-second ...
07.12.2022Sisters Get Concussion Diagnostic Funded, FDA Approved, And ReimbursedRosina Samadani, president and CEO at Oculogica, a healthtech company focused on measuring brain ... [+] impairment from concussions and cannabisOculogica, uses eye-tracking devices to measure brain health
18.05.2021Oculogica Receives Department of Defense Grant to Develop Wearable Concussion Diagnostic with Pre-eminent PartnersSofia Fund portfolio company Oculogica receives $2M U.S. Army grant to develop wearable version of its technology
21.05.2020Colorado startup will relocate to Green Bay after TitletownTech investmentA Denver startup is moving its headquarters to Green Bay this year after receiving funding from TitletownTech, a tech hub and venture fund led by the Green Bay Packers and Microsoft. TitletownTech announced this week that it invested in Qua...
21.01.2020Concussion Tech Startup Oculogica Raises $8M in Round Led By Wisconsin's Titletown TechTitletownTech, a tech hub and venture fund led by the Green Bay Packers and Microsoft, has announced the details of one of the first startup investments from its $25 million venture capital fund. TitletownTech announced Thursday that it led...
16.01.2020TitletownTech Leads $8M Round in Concussion Diagnosis StartupTitletownTech, a tech hub and venture fund led by the Green Bay Packers and Microsoft, has announced the details of one of the first startup investments from its $25 million venture capital fund. TitletownTech announced Thursday that it led...
21.12.2019Sofia Fund Invests in Health Tech Startup Clinician NexusAngel team caps off record year of investing in woman-owned businesses
04.01.2019Concussion diagnostic device EyeBox receives FDA nodNew York-based startup Oculogica is trying to change that with its EyeBox device, the first non-invasive and baseline-free diagnostic tool for the detection of concussions. The company received De Novo marketing approval of its product by t...
15.02.2018Concussion detection tech scores milestone with FDA clearance for brain injury diagnosticThe FDA clearance for Banyan’s blood test is a milestone for concussion diagnostics. Many different companies have also worked towards this goal. Last year Abbott received an $11.2 million contract from the U.S. Department of Defense (DOD) ...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In